112
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Seroprevalence of Hepatitis B and C Viruses and Their Associated Factors Among Military Personnel at Military Camps in Central Gondar, Ethiopia: A Cross-Sectional Study

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 1407-1417 | Received 18 Dec 2023, Accepted 05 Apr 2024, Published online: 11 Apr 2024

References

  • Ayele AG, Gebre-Selassie S. Prevalence and risk factors of hepatitis B and hepatitis C virus infections among patients with chronic liver diseases in public hospitals in Addis Ababa, Ethiopia. Int Scholarly Res Notices. 2013;2013:1–7.
  • Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age‐specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333–1342. doi:10.1002/hep.26141
  • Ott J, Stevens G, Groeger J, Wiersma S. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212–2219. doi:10.1016/j.vaccine.2011.12.116
  • Malhotra R, Soin D, Grover P, Galhotra S, Khutan H, Kaur N. Hepatitis B virus and hepatitis C virus co-infection in hemodialysis patients: a retrospective study from a tertiary care hospital of North India. J Nat Sci Biol Med. 2016;7(1):72. doi:10.4103/0976-9668.175076
  • Caccamo G, Saffioti F, Raimondo G. Hepatitis B virus and hepatitis C virus dual infection. World J Gastroenterol. 2014;20(40):14559. doi:10.3748/wjg.v20.i40.14559
  • World Health Organization. [ cited 2024 February 19]. Available from: https://www.who.int/health-topics/hepatitis#tab=tab_1. Accessed April 8, 2024.
  • Hsu Y-C, Huang DQ, Nguyen MHJNRG. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20(8):1–14.
  • Razavi-Shearer D, Blach S, Gamkrelidze I, et al. The disease burden of hepatitis B and hepatitis C from 2015 to 2030: the long and winding road. J Hepatol. 2022;77:S43.
  • Bane A, Patil A, Khatib M. Healthcare cost and access to care for viral hepatitis in Ethiopia. Int J Innov Appl Stud. 2014;9(4):1718.
  • World Health Organization. Global policy report on the prevention and control of viral hepatitis in WHO member states; 2013.
  • Shiferaw F, Letebo M, Bane A, Idohou-Dossou N, Sow PS, Wade S. Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia. BMC Public Health. 2016;16(1):1–13. doi:10.1186/s12889-015-2639-8
  • Belyhun Y, Maier M, Mulu A, Diro E, Liebert UG. Hepatitis viruses in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2016;16(1):1–14. doi:10.1186/s12879-016-2090-1
  • Owiti JA, Greenhalgh T, Sweeney L, Foster GR, Bhui KS. Illness perceptions and explanatory models of viral hepatitis B & C among immigrants and refugees: a narrative systematic review. BMC Public Health. 2015;15(1):1–17. doi:10.1186/s12889-015-1476-0
  • Alavian SM. Military personals should be vaccinated against hepatitis B infection. J Arch Mil Med. 2014;2(1). doi:10.5812/jamm.16450
  • Sobuh IM Risk factors of Hepatitis B transmission in north west bank: a case-control study; 2013.
  • Birku T, Gelaw B, Moges F, Assefa A. Prevalence of hepatitis B and C viruses infection among military personnel at Bahir Dar Armed Forces General Hospital, Ethiopia. BMC Res Notes. 2015;8(1):1–6. doi:10.1186/s13104-015-1719-2
  • Wondmagegn M, Wondimeneh Y, Getaneh A, Ayalew G. Seroprevalence of hepatitis B virus, hepatitis C virus, syphilis and associated factors among female sex workers in Gondar Town, Northwest Ethiopia. Infect Drug Resist. 2022;Volume 15:5915–5927. doi:10.2147/IDR.S380952
  • Million Y, Teklu T, Alemu S, Ferede A, Belachew T, Desta K. Hepatitis B and hepatitis C viral infections and associated factors among patients with diabetes visiting Gondar Referral Teaching Hospital, Northwest Ethiopia: a comparative cross-sectional study. J Hepatocell Carcinoma. 2019;Volume 6:143–150. doi:10.2147/JHC.S222609
  • Kasew D, Wondmagegn M, Bayleyegn B. Seroprevalence of hepatitis B and C virus among highly active antiretroviral therapy experienced children in Gondar, Ethiopia. Trop Med Health. 2022;50(1):1–9. doi:10.1186/s41182-022-00489-2
  • Getie B, Ayalew G, Amsalu A, Ferede G, Yismaw G, Tessema B. Seroprevalence and associated factors of hepatitis B and C virus among pulmonary tuberculosis patients attending health facilities in Gondar Town, Northwest Ethiopia. Infect Drug Resist. 2021;14:3599–3608. doi:10.2147/IDR.S327503
  • Tesfa H, Biadgo B, Getachew F, Tegegne K, Yismaw G, Muluye D. Seroprevalence of hepatitis B and C virus infection among patients attending serology laboratory of Gondar University Hospital. BMC Res Notes. 2013;6(1):1–4. doi:10.1186/1756-0500-6-164
  • Anagaw B, Shiferaw Y, Anagaw B, et al. Seroprevalence of hepatitis B and C viruses among medical waste handlers at Gondar town health institutions, Northwest Ethiopia. BMC Res Notes. 2012;5(1):1–10. doi:10.1186/1756-0500-5-55
  • Tigabu A, Engda T, Mekonnen F. Seroprevalence of transfusion transmissible viral infections (HIV, HBV and HCV) among voluntary blood donors at university of Gondar comprehensive specialized hospital, Gondar; Northwest Ethiopia. BMC Infect Dis. 2019;19(1):1–8. doi:10.1186/s12879-019-3950-2
  • Patel NH, Meier-Stephenson V, Genetu M, et al. Prevalence and genetic variability of occult hepatitis B virus in a human immunodeficiency virus positive patient cohort in Gondar, Ethiopia. PLoS One. 2020;15(11):e0242577. doi:10.1371/journal.pone.0242577
  • Beijing wantai biological pharmacy enterprise co. L, Beijing, China; 2020 Available from: https://www.ystwt.cn/hepatitis-b/. Accessed April 8, 2024.
  • World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194.
  • Evlampidou I, Hickman M, Irish C, et al. Low hepatitis B testing among migrants: a cross-sectional study in a UK city. Br J Gen Pract. 2016;66(647):e382–e91. doi:10.3399/bjgp16X684817
  • Lazarus J, Safreed-Harmon K, Sperle I Global policy report on the prevention and control of viral hepatitis in WHO member states; 2013.
  • Alavian S, Rajai M, Arab M, et al. Viral hepatitis in Iranian armed forces: prevalence of HBV and HCV in the wounded-in-action (WIA). Hepat Mon. 2005;5(4):129–131.
  • Diop M, Diouf A, Seck SM, et al. Prevalence of hepatitis B surface antigen and its associated factors in Senegalese military personnel sent on mission to Darfur. Pan Afr Med J. 2017;26:154. doi:10.11604/pamj.2017.26.154.11594
  • Ndiaye AA, Fall IS, Lo G, et al. HBsAg seroprevalence among Senegalese militaries. Mil Med Res. 2015;2(1):1–5.
  • Tsega E, Krawczynski K, Hansson BG, et al. Outbreak of acute hepatitis E virus infection among military personnel in northern Ethiopia. J Med Virol. 1991;34(4):232–236. doi:10.1002/jmv.1890340407
  • Kupcinskas L, Petrauskas D, Petrenkiene V, Saulius K. Prevalence of hepatitis B virus chronic carriers and risk factors for hepatitis B virus infection among Lithuanian army soldiers. Mil Med. 2007;172(6):625–627. doi:10.7205/MILMED.172.6.625
  • Mirza IA, Mirza SH, Irfan S, Siddiqi R, Tariq WUZ, Janjua AN. Seroprevalence of hepatitis B and C in young adults seeking recruitment in armed forces. Pakistan Armed Forces Med J. 2006;56(2):192–197.
  • Sherif TB. Seroprevalence of hepatitis B and C in healthy adult male recruits. Pak J Med Sci. 2006;17(4).
  • Wang T, Dai Y, Lu W, et al. An epidemiological survey of HBV infection and low-level HBsAg in military camps in eastern China. Medicine. 2018;97(38):e12201.
  • German V, Giannakos G, Kopterides P, Liaskonis K, Falagas ME. Serologic indices of hepatitis B virus infection in military recruits in Greece (2004–2005). BMC Infect Dis. 2006;6(1):1–6. doi:10.1186/1471-2334-6-163
  • O’Connor SM, Mixson-Hayden T, Ganova-Raeva L, et al. Integrated HIV surveillance finds recent adult hepatitis B virus (HBV) transmission and intermediate HBV prevalence among military in uncharacterized Caribbean country. PLoS One. 2019;14(10):e0222835. doi:10.1371/journal.pone.0222835
  • Da Motta LR, Adami ADG, Sperhacke RD, et al. Hepatitis B and C prevalence and risk factors among young men presenting to the Brazilian Army: a strobe-compliant national survey-based cross-sectional observational study. Medicine. 2019;98(32):e16401. doi:10.1097/MD.0000000000016401
  • Brown AE, Ross DA, Simpson AJ, et al. Prevalence of markers for HIV, hepatitis B and hepatitis C infection in UK military recruits. Epidemiol Infect. 2011;139(8):1166–1171. doi:10.1017/S0950268810002712
  • Suryam V, Kathuria S, Karunakaran S. A study of seroprevalence of hepatitis B and hepatitis C among troops in armed forces. Med J Armed Forces India. 2011;67(3):257. doi:10.1016/S0377-1237(11)60053-1
  • Puri P, Sharma P, Nagpal A. Viral hepatitis in India: armed forces perspective. Med J Armed Forces India. 2016;72(3):201. doi:10.1016/j.mjafi.2016.07.004
  • Villar LM, Scalioni LP, Cruz HM, et al. Prevalence of hepatitis B and C virus infections among military personnel. Braz J Infect Dis. 2015;19(3):285–290. doi:10.1016/j.bjid.2015.02.002
  • Todd CS, Nasir A, Mansoor GF, et al. Cross-sectional assessment of prevalence and correlates of blood-borne and sexually-transmitted infections among Afghan National Army recruits. BMC Infect Dis. 2012;12(1):1–9. doi:10.1186/1471-2334-12-196
  • Umumararungu E, Ntaganda F, Kagira J, Maina N. Prevalence of hepatitis C virus infection and its risk factors among patients attending Rwanda military hospital, Rwanda. Biomed Res Int. 2017;2017:1–7. doi:10.1155/2017/5841272
  • Taye M, Daka D, Amsalu A, Hussen S. Magnitude of hepatitis B and C virus infections and associated factors among patients scheduled for surgery at Hawassa University comprehensive specialized hospital, Hawassa City, Southern Ethiopia. BMC Res Notes. 2019;12(1):1–6. doi:10.1186/s13104-019-4456-0
  • Konstantinou D, Deutsch M. The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management. Ann Gastroenterol. 2015;28(2):221.
  • Yu G, Chi X, Wu R, et al. Replication inhibition of hepatitis B virus and hepatitis C virus in co-infected patients in Chinese population. PLoS One. 2015;10(9):e0139015. doi:10.1371/journal.pone.0139015
  • Angtuaco TL, Jensen DM. HBV and HCV co-infection. Chronic Viral Hepatitis. 2002;109–121.
  • Beckman LJ, Ackerman KT. Women, alcohol, and sexuality. Recent Dev Alcohol. 1995;12:267–285. doi:10.1007/0-306-47138-8_18
  • Thompson JC, Kao TC, Thomas RJ. The relationship between alcohol use and risk-taking sexual behaviors in a large behavioral study. Prev Med. 2005;41(1):247–252. doi:10.1016/j.ypmed.2004.11.008
  • Gitto S, Vitale G, Villa E, Andreone P. Update on alcohol and viral hepatitis. J Clin Transl Hepatol. 2014;2(4):228. doi:10.14218/JCTH.2014.00030
  • Ong A, Wong VWS, Wong GLH, Chan HLY. The effect of caffeine and alcohol consumption on liver fibrosis–a study of 1045 Asian hepatitis B patients using transient elastography. Liver Int. 2011;31(7):1047–1053. doi:10.1111/j.1478-3231.2011.02555.x
  • Abdulai MA, Baiden F, Adjei G, Owusu-Agyei S. Low level of hepatitis B knowledge and awareness among pregnant women in the Kintampo north municipality: implications for effective disease control. Ghana Med J. 2016;50(3):157–162. doi:10.4314/gmj.v50i3.7
  • Singh M, Kotwal A, Gupta R, Adhya S, Chatterjee K, Jayaram J. Sero-epidemiological and behavioural survey of HIV, HBV and HCV amongst Indian armed forces trainees. Med J Armed Forces India. 2010;66(1):50–54. doi:10.1016/S0377-1237(10)80093-0
  • Gupta E, Bajpai M, Sharma P, Shah A, Sarin S. Unsafe injection practices: a potential weapon for the outbreak of blood borne viruses in the community. Ann Med Health Sci Res. 2013;3(2):177. doi:10.4103/2141-9248.113657
  • Kengibe PY, Makulo J-R-R, Nlandu YM, et al. Response to single dose hepatitis B vaccine in Congolese non-HIV hemodialysis patients: a prospective observational study. Pan Afr Med J. 2019;34. doi:10.11604/pamj.2019.34.122.19603
  • Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? Hepatology. 2010;52(4):1497–1505. doi:10.1002/hep.23808
  • Silverman AL, Puccio JE, Kulesza GW, McCray DG, Gordon SCJAJo G. HCV RNA is present in the menstrual blood of women with chronic hepatitis C infection. Am J Gastroenterol. 1994;89(8).